Comparative proteomic profiling of the ovine and human PBMC inflammatory response
A Elkhamary, I Gerner, A Bileck, GL Oreff, C Gerner… - Scientific Reports, 2024 - nature.com
Understanding the cellular and molecular mechanisms of inflammation requires robust
animal models. Sheep are commonly used in immune-related studies, yet the validity of …
animal models. Sheep are commonly used in immune-related studies, yet the validity of …
Treatment with BKI-1748 after Toxoplasma gondii systemic dissemination in experimentally infected pregnant sheep improves fetal and lamb mortality and morbidity …
R Sánchez-Sánchez, A Huertas-López… - Antimicrobial Agents …, 2024 - journals.asm.org
Drug development for congenital toxoplasmosis is challenging since first-line therapy has a
high rate of adverse effects and exhibits suboptimal efficacy. Bumped kinase inhibitors …
high rate of adverse effects and exhibits suboptimal efficacy. Bumped kinase inhibitors …
Interacción hospedador/parásito en la toxoplasmosis ovina: influencia de la virulencia del parásito sobre la respuesta inmunitaria y la patogenia de la enfermedad
R Vallejo García - 2023 - digital.csic.es
De este modo se observó que la prevalencia general de CE en la población analizada fue
de 7, 9%(97/1221), 6, 71%(21/313) de menores de 18 años y el 8, 4%(76/908) de los …
de 7, 9%(97/1221), 6, 71%(21/313) de menores de 18 años y el 8, 4%(76/908) de los …